The Natural (and Unnatural( History of Hypertrophic Obstructive Cardiomyopathy
A MULTICENTER STUDY
- SHAH, PRAVIN M. M.D.
- ADELMAN, ALLAN G. M.D.
- WIGLE, E. DOUGLAS M.D.
- GOBEL, FREDARICK L. M.D.
- BURCHELL, HOWARD B. M.D.
- HARDARSON, T. M.D.
- CURIEL, R. M.D.
- de la CALZADA, C. M.D.
- OAKLEY, CELIA M. M.D.
- GOODWIN, JOHN F. M.D.
The records of 190 patients have been reviewed in a multicenter cooperative study to evaluate the course of hypertrophic obstructive cardiomyopathy. The criteria for inclusion in the study were: (a) demonstration of left ventricular-aortic pressure difference in systole either at rest or on provocation; and (b) minimum follow-up period of one year. The 190 patients were followed for 981 patient-years (average, 5.2 years per patient).
The significant findings include: (1) older patients tended to be more symptomatic, with outstanding exceptions; (2) sudden death was the most common cause of demise, accounting for 26 deaths of a total of 49; (3) patients who successfully underwent ventriculomyotomy had a lower incidence of sudden death, suggesting some protection against this complication; (4) no correlation was found between age, sex, length of follow-up, or severity of presenting symptoms and the occurrence of sudden death; (5) the vast majority (83%) of the surviving patients remained clinically stable or were improved over the relatively short follow-up period in this study; (6) surgery in the form of ventriculomyotomy often provided lasting clinical and hemodynamic improvement, although the operative mortality was high (26% overall); (7) clinical response to propranolol was variable; (8) development of a clinical picture dominated by congestive heart failure with loss of outflow obstruction was extremely rare; and (9) excluding surgical and unrelated deaths, the overage attrition rate from this disorder was 3.4% per year.